Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)
China · Delayed Price · Currency is CNY 14.86
+0.05 (0.34%)
Feb 4, 2026, 3:04 PM CST
SHE:002365 Revenue
Qianjiang Yongan Pharmaceutical had revenue of 209.77M CNY in the quarter ending September 30, 2025, with 8.75% growth. This brings the company's revenue in the last twelve months to 797.25M, up 1.07% year-over-year. In the year 2024, Qianjiang Yongan Pharmaceutical had annual revenue of 838.81M, down -13.78%.
Revenue (ttm)
797.25M
Revenue Growth
+1.07%
P/S Ratio
5.37
Revenue / Employee
857.26K
Employees
930
Market Cap
4.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 838.81M | -134.08M | -13.78% |
| Dec 31, 2023 | 972.89M | -489.56M | -33.48% |
| Jan 1, 2023 | 1.46B | -102.96M | -6.58% |
| Jan 1, 2022 | 1.57B | 392.56M | 33.47% |
| Dec 31, 2020 | 1.17B | -197.59M | -14.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Ningbo Menovo Pharmaceutical | 1.54B |
| LanZhou Foci Pharmaceutical | 895.75M |
| Shandong Wohua Pharmaceutical | 816.95M |
| Tibet AIM Pharm. | 628.02M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 619.88M |